INCR InterCure Ltd: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

The medical cannabis sector remains stable due to strict compliance and exclusive contracts held by InterCure Ltd. (INCR). Leading positions in Israel and the EU are sustained by competent management focused on expansion. Stable cash flow secures its status as the largest distributor with an extensive pharmacy network. This chart of consensus EPS growth estimates for the coming year demonstrates market expectations, where 0.00 expresses the current value of the metric.

INCR - Proyeksi tambahing bathi saben saham ing taun ngarep InterCure Ltd ing rentang 04.07.2022 - 14.11.2026

InterCure Ltd - rincian analitis lan metrik utama (INCR)

- rega saham lan konsensus proyeksi valuasi:

Rega saham InterCure|INCR - Target median analis

- data kapitalisasi saham perusahaan:

Nilai pasar INCR|INCR - Nilai Bisnis

- rincian nilai buku perusahaan:

Nilai Akuntansi saben Saham InterCure|INCR - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku intercure.co|INCR - Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- statistik bathi lan rasio pasar:

INCR - Penghasilan resik perusahaan|Bathi mangsa ngarep InterCure Ltd.|INCR - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep InterCure Ltd.|INCR - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan InterCure|INCR - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) InterCure|INCR - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan intercure.co|INCR - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep InterCure Ltd.

- informasi babagan volume dodolan lan pendapatan:

INCR - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan InterCure|INCR - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S Canndoc

Analisis komprehensif perusahaan:intercure.co

InterCure Ltd. (INCR) international expansion through partnerships with European brands directly determines the future profitability of the business. This metric aggregates analysts' consensus forecasts for changes in earnings per share, measuring the year-over-year growth rates of net income. Analyzing the one-year forward EPS growth rate allows for an assessment of the company's resilience to market cycles and the risk of asset overvaluation.

Pesaing utama